SCHEMBL7207786

SCHEMBL7207786

CCC(C)C(C(=O)c1ccc(C(C)C)[c]c1C(C)C)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.41
CHRM4 P08173 2/20 0.41
CHRM1 P11229 2/20 0.41
CHRM3 P20309 2/20 0.41
CYP2D6 P10635 2/20 0.40
CHRM5 P08912 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
LMNA P02545 6/20 0.33
HSD17B10 Q99714 2/20 0.33
CRHBP P24387 1/20 0.33
CRHR2 Q13324 1/20 0.33
PGR P06401 1/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
HTR2A P28223 1/20 0.33
HRH1 P35367 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7211246 0.84 LMNA (0.47) KMT2AMEN1SMN1; SMN2LMNAHSD17B10
SCHEMBL7207547 0.81 L3MBTL1 (0.43) CHRM2CHRM4CHRM1CHRM3SMN1; SMN2
SCHEMBL7211283 0.81 PTGS2 (0.40) KMT2AMEN1SMN1; SMN2LMNAHSD17B10
SCHEMBL7207787 0.77 CHRM2 (0.43) CHRM2CHRM4CHRM1CHRM3CYP2D6
SCHEMBL7206377 0.76 LMNA (0.37) SMN1; SMN2LMNAALDH1A1HPGDPOLB
SCHEMBL7206890 0.72 CHRM3 (0.44) CHRM2CHRM1CHRM3CYP2D6KMT2A
SCHEMBL7211946 0.72 CHRM3 (0.45) CHRM2CHRM1CHRM3CYP2D6KMT2A
SCHEMBL23872457 0.70 CYP2D6 (0.61) CHRM2CHRM4CHRM1CHRM3CYP2D6
SCHEMBL4921518 0.70 CYP2D6 (0.61) CHRM2CHRM4CHRM1CHRM3CYP2D6
SCHEMBL499471 0.70 CYP2D6 (0.61) CHRM2CHRM4CHRM1CHRM3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841913-B1 USE OF SULFAMIC ACID DERIVATIVES, ACYL SULFONAMIDES OR SULFONYL CARBAMATES FOR THE MANUFACTURE OF A MEDICAMENT FOR LOWERING LIPOPROTEIN LEVELS WARNER LAMBERT CO (US) 2003-02-05 EP claimed